Hartmut Schlüter

Hartmut Schlüter is a Professor at the Institute of Clinical Chemistry and Laboratory Medicine at the University Medical Center Hamburg-Eppendorf (UKE). His extensive research profile demonstrates leadership in proteomics, glycomics, and mass spectrometry with significant contributions to cancer research and clinical applications. As evidenced by his numerous publications in high-impact journals, Professor Schlüter maintains an active research program with collaborations spanning multiple disciplines and institutions.

Professor Schlüter's research interests center on the application of advanced proteomic and glycomic techniques to understand disease mechanisms, particularly in cancer. His work spans multiple areas including extracellular vesicle analysis, N-glycosylation profiling, metabolomics, and the development of novel analytical methods. His research has significant implications for cancer diagnostics, biomarker discovery, and therapeutic development, with particular focus on breast cancer, prostate cancer, and various other malignancies. The interdisciplinary nature of his work bridges biochemistry, molecular biology, and clinical medicine to address critical challenges in disease detection and treatment.

Analysis of Professor Schlüter's recent publications reveals a strong trend toward multi-omics approaches, particularly integrating proteomics with glycomics to understand cancer biology at a systems level. His work increasingly focuses on extracellular vesicles as diagnostic and therapeutic tools, with applications in liquid biopsy development for early cancer detection. The research also demonstrates growing interest in spatially resolved proteomics using advanced tissue sampling techniques like nanosecond infrared laser ablation, enabling unprecedented cellular-level analysis of tissue architecture.

Professor Schlüter appears to be actively involved in mentoring and collaborative research, with numerous publications featuring multiple co-authors from diverse research groups. His work is supported by various research projects including international collaborations and funding from organizations such as the China Scholarship Council, DAAD, and Horizon 2020 Marie Sklodowska-Curie Actions.

His laboratory appears to specialize in advanced proteomic and glycomic analysis, with particular expertise in mass spectrometry-based techniques. The research team has developed specialized methodologies for tissue sampling, proteoform analysis, and glycan characterization that have been applied across multiple disease contexts including cancer, cardiovascular disease, and neurological disorders.